Zobrazeno 1 - 10
of 59
pro vyhledávání: '"Belén, de la Fuente"'
Autor:
Julio Collazos, Laura Pérez-Is, Belén de la Fuente, Luis Morano, Maria Rivas-Carmenado, Manuel Rodriguez, Adolfo Romero-Favela, Galilea de Jesús Fonseca-González, Santiago Melón, Javier Diaz-Arias, Eulalia Valle-Garay, Víctor Asensi
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-9 (2024)
Abstract Untreated HCV mono and HCV/HIV coinfected women have lower degrees of liver fibrosis (LF) compared to men. Direct acting antiviral (DAA) therapy attains viral eradication in > 90% of patients with progressive LF decline in parallel. Gender-r
Externí odkaz:
https://doaj.org/article/f92bfb26578149c68d9dad4ae2faf312
Autor:
Laura Pérez-Is, Julio Collazos, Belén de la Fuente, Luis Morano, Maria Rivas-Carmenado, Manuel Rodriguez, Adolfo Romero-Favela, Galilea de Jesús Fonseca–González, Santiago Melón, Eulalia Valle-Garay, Víctor Asensi
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-12 (2022)
Abstract Long term liver fibrosis (LF) changes and their best -monitoring non-invasive markers (NILFM) after effective anti-HCV DAA therapy are little- known. Matrix-metalloproteases (MMPs) and their tissue-inhibitors (TIMPs) are pivotal in liver inf
Externí odkaz:
https://doaj.org/article/867f941fffd14a2e8aabf35c29992c8d
Autor:
Ramón Teira, Helena Diaz-Cuervo, Filipa Aragão, Josefa Muñoz, Pepa Galindo, MaríaDolores Merino, Belén de la Fuente, María Antonia Sepúlveda, Pere Domingo, Josefina García, Manuel Castaño, Esteve Ribera, Paloma Geijo, Alberto Romero, Joaquim Peraire, Elisabeth Deig, Bernardino Roca, Elisa Martínez, Vicente Estrada, Marta Montero, Juan Berenguer, Nuria Espinosa
Publikováno v:
HIV Research & Clinical Practice, Vol 22, Iss 3, Pp 78-85 (2021)
Background: Evidence from clinical practice on the effects of switching from emtricitabine/tenofovir disoproxil fumarate (F/TDF) to emtricitabine/tenofovir alafenamide (F/TAF)-based triple-therapy (TT) regimens on renal parameters is limited. Objecti
Externí odkaz:
https://doaj.org/article/146d01a4afc14743af4337fe2e32fdea
Autor:
Julio Collazos, Belén de la Fuente, Javier de la Fuente, Alicia García, Helena Gómez, María Rivas-Carmenado, Tomás Suárez-Zarracina, Enrique García-Carús, Silvia Suárez-Diaz, Héctor Enríquez, Paula Sánchez, María Alonso, Ian López-Cruz, Manuel Martín-Regidor, Ana Martínez-Alonso, José Guerra, Arturo Artero, Marino Blanes, Víctor Asensi
Publikováno v:
International Journal of Infectious Diseases, Vol 104, Iss , Pp 584-591 (2021)
Objectives: Sex differences in adult cellulitis, a frequent cause of hospitalization, have not been analyzed. These differences were investigated in a large cellulitis series. Methods: This was a prospective observational study of 606 Spanish hospita
Externí odkaz:
https://doaj.org/article/48c9f7dc689f482395948a4c44f37136
Autor:
Ramón Teira, Helena Diaz-Cuervo, Filipa Aragão, Sophie Marguet, Belén de la Fuente, Maria Jose Muñoz, Nadia Abdulghani, Esteban Ribera, Pere Domingo, Elisabeth Deig, Joaquim Peraire, Bernardino Roca, Marta Montero, Maria José Galindo, Alberto Romero, Nuria Espinosa, Fernando Lozano, María Dolores Merino, Elisa Martínez, Paloma Geijo, Vicente Estrada, Josefina García, M Antonia Sepúlveda, Juan Berenguer
Publikováno v:
PLoS ONE, Vol 16, Iss 4, p e0249515 (2021)
BackgroundSince 1996, the standard of care (SOC) therapy for HIV treatment has consisted of a backbone of two nucleoside analogue reverse transcriptase inhibitors (NRTI) paired with a third agent. Use of two-drug combinations (2DC) has been considere
Externí odkaz:
https://doaj.org/article/a21ffaa9fa9b4ef6a70b618007f4be3a
Autor:
Julio Collazos, Belén de la Fuente, Alicia García, Helena Gómez, C Menéndez, Héctor Enríquez, Paula Sánchez, María Alonso, Ian López-Cruz, Manuel Martín-Regidor, Ana Martínez-Alonso, José Guerra, Arturo Artero, Marino Blanes, Javier de la Fuente, Víctor Asensi
Publikováno v:
PLoS ONE, Vol 13, Iss 9, p e0204036 (2018)
BACKGROUND:Cellulitis is a frequent cause of hospital admission of adult patients. Increasing prevalence of multiresistant microorganisms, comorbidities, predisposing factors and medical and surgical therapies might affect cellulitis response and rec
Externí odkaz:
https://doaj.org/article/92eefbf644da4477ba311da25e569f71
Autor:
Alicia Martínez García, Marino Blanes, Tomás Suárez-Zarracina, Silvia Suárez-Díaz, Ana Martinez-Alonso, María J. Alonso, José Guerra, Julio Collazos, Javier de la Fuente, Enrique Garcia-Carus, Ian López-Cruz, Maria Rivas-Carmenado, Arturo Artero, Manuel Martin-Regidor, Belén de la Fuente, Paula Sanchez, Victor Asensi, Helena Gomez, Hector Enriquez
Publikováno v:
International Journal of Infectious Diseases, Vol 104, Iss, Pp 584-591 (2021)
Objectives: Sex differences in adult cellulitis, a frequent cause of hospitalization, have not been analyzed. These differences were investigated in a large cellulitis series. Methods: This was a prospective observational study of 606 Spanish hospita
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::89b212cfce70e985d57f1c20459f0b90
https://doi.org/10.1016/j.ijid.2021.01.044
https://doi.org/10.1016/j.ijid.2021.01.044
Autor:
Ramón Teira, Helena Diaz-Cuervo, Filipa Aragão, Manuel Castaño, Alberto Romero, Bernardino Roca, Marta Montero, Maria José Galindo, Maria Jose Muñoz-Sánchez, Nuria Espinosa, Joaquim Peraire, Elisa Martínez, Belén de la Fuente, Pere Domingo, Elisabeth Deig, María Dolores Merino, Paloma Geijo, Vicente Estrada, María Antonia Sepúlveda, Josefina García, Juan Berenguer, Adriá Currán
Publikováno v:
Infectious Diseases and Therapy
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
Consejo Superior de Investigaciones Científicas (CSIC)
Scientia
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
Consejo Superior de Investigaciones Científicas (CSIC)
Scientia
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
Introduction Standard therapy for HIV treatment has consisted of two nucleoside analogue reverse transcriptase inhibitors (NRTI) paired with a third agent. Use of two-drug regimens (2DR) has been considered for selected patients in part to avoid toxi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::72c9d2be82c5d83c38b512ef95c9cef4
https://pubmed.ncbi.nlm.nih.gov/35399147
https://pubmed.ncbi.nlm.nih.gov/35399147
Autor:
Belén de la Fuente, Luis Morano, Victor Asensi, Galilea de Jesús Fonseca–González, Julio Collazos, Laura Pérez-Is, S. Melón, Eulalia Valle-Garay, Manuel Rodríguez, Maria Rivas-Carmenado, Adolfo Romero-Favela
Long term liver fibrosis (LF) changes and their best -monitoring non-invasive tools after effective anti-HCV DAA therapy are little- known. Matrix-metalloproteases (MMPs) and their tissue-inhibitors (TIMPs) are pivotal in liver inflammation repair .T
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::eba4b51c65b3f9b05fb784b0b9f13360
https://doi.org/10.21203/rs.3.rs-841641/v1
https://doi.org/10.21203/rs.3.rs-841641/v1
Autor:
Laura Pérez-Is, Julio Collazos, Belén de la Fuente, Luis Morano, Maria Rivas-Carmenado, Manuel Rodriguez, Adolfo Romero-Favela, Galilea de Jesús Fonseca–González, Santiago Melón, Eulalia Valle-Garay, Víctor Asensi
Publikováno v:
Scopus
RUO. Repositorio Institucional de la Universidad de Oviedo
instname
RUO. Repositorio Institucional de la Universidad de Oviedo
instname
Long term liver fibrosis (LF) changes and their best -monitoring non-invasive markers (NILFM) after effective anti-HCV DAA therapy are little- known. Matrix-metalloproteases (MMPs) and their tissue-inhibitors (TIMPs) are pivotal in liver inflammation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::47dc1060af290d8c5ec81ec3bf0e1665
https://pubmed.ncbi.nlm.nih.gov/35264591
https://pubmed.ncbi.nlm.nih.gov/35264591